Human cell receptors: potential drug targets to combat COVID-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Clinical Biochemistry,Biochemistry
Link
https://link.springer.com/content/pdf/10.1007/s00726-021-02991-z.pdf
Reference206 articles.
1. Aghai ZH, Kode A, Saslow JG, Nakhla T, Farhath S, Stahl GE et al (2007) Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. Pediatr Res. https://doi.org/10.1203/PDR.0b013e318142582d
2. Amraie R, Napoleon MA, Yin W, Berrigan J, Suder E, Zhao G et al (2020) CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells. BioRxiv Prepr Serv Biol. https://doi.org/10.1101/2020.06.22.165803
3. Anand P, Puranik A, Aravamudan M, Venkatakrishnan AJ, Soundararajan V (2020) SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. Elife. https://doi.org/10.7554/eLife.58603
4. Aoshiba K, Yokohori N, Nagai A (2003) Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. https://doi.org/10.1165/rcmb.2002-0090OC
5. Arendse LB, Jan DAH, Poglitsch M, Touyz RM, Burnett JC, Llorens-Cortes C et al (2019) Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev. https://doi.org/10.1124/pr.118.017129
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Experimental and analytical pipeline for sub-genomic RNA landscape of coronavirus by Nanopore sequencer;Microbiology Spectrum;2024-04-02
2. Targets of SARS-CoV-2: therapeutic implications for COVID-19;Stem Cells;2024
3. Comparative clinical investigation of blood profiling in COVID-19 patients;Stem Cells;2024
4. Clinical investigation of COVID-19 prevention and treatment;Stem Cells;2024
5. Computational approaches for hematopoietic stem cells;Computational Biology for Stem Cell Research;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3